TXNL4B

Thioredoxin-Like 4B Gene

Gene Information Card

Symbol TXNL4B
Full Name Thioredoxin-Like 4B
Gene Type Protein coding
Chromosomal Location 16q22.1
NCBI Gene ID 54957 ncbi.nlm.nih.gov/gene/54957
Ensembl ID ENSG00000140987
UniProt ID Q9NX46
OMIM ID 611218
HGNC ID 25952
Aliases DIM1, DIM1L, DIMT1L, TXNL4

Description

TXNL4B encodes a thioredoxin-like protein that is a component of the U5 small nuclear ribonucleoprotein (snRNP) complex, involved in pre-mRNA splicing. The protein contains a thioredoxin domain and is essential for spliceosome assembly and function.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
No specific disease association reported in ClinVar or OMIM Not applicable No evidence

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 15.2 Medium
Lymph node 12.8 Medium
Spleen 11.5 Medium
Bone marrow 10.9 Medium
Brain 8.3 Low
Cell Line Expression
Cell Line nTPM Notes
HEK 293 18.5 High expression
HeLa 14.2 Medium expression
K562 12.1 Medium expression
HepG2 9.8 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
No pathogenic variants reported in ClinVar Not applicable Not applicable Not applicable
Mutation functional classification

Loss of Function (LOF)

No loss-of-function mutations documented in ClinVar or COSMIC.

Gain of Function (GOF)

No gain-of-function mutations documented.

Dominant Negative (DN)

No dominant-negative mutations documented.

Pathways

• hsa03040 - Spliceosome (KEGG)
• R-HSA-72163 - mRNA Splicing - Major Pathway (Reactome)

Protein Summary

TXNL4B is a 142-amino acid protein (16 kDa) with a thioredoxin-like fold. It localizes to the nucleus and is a stable component of the U5 snRNP, interacting with other spliceosomal proteins to facilitate pre-mRNA splicing. The protein is ubiquitously expressed with highest levels in testis and lymphoid tissues.

Related Products

Product name Cat.No. Species Gene ID
No Data
Contact Us
*
*
*
How did you hear about us: